Pharma & Life Sciences
Move faster from discovery to market. Operate more efficiently. Stay compliant.
Pharmaceutical and life sciences companies face enormous pressure to accelerate timelines and reduce cost — while operating in one of the most heavily regulated environments in the world. AI creates leverage at every stage when governed correctly.
Business pressure
What's keeping leadership up at night.
- Drug development timelines and costs that are unsustainable at current scale
- Commercial teams overwhelmed by data but under-equipped to act on it
- Pharmacovigilance and regulatory workloads growing faster than available capacity
- Pressure to demonstrate AI governance and responsible use to regulators and boards
Where AI creates value
AI in pharma creates value in two distinct areas: accelerating the science (clinical trial design, literature synthesis, biomarker identification) and improving the operating business (commercial execution, pharmacovigilance, medical affairs, regulatory submissions). QR/OS™ focuses on the operating business — where speed, governance, and adoption are the critical variables.
Use cases
Where AI creates measurable value.
Medical affairs content and literature synthesis
Use AI to synthesize scientific literature, generate MSL-ready content, and maintain up-to-date disease area knowledge — improving speed and consistency across medical affairs.
Pharmacovigilance case processing
Automate intake, triage, and narrative generation for adverse event reports — reducing manual processing time while maintaining compliance and audit readiness.
Commercial intelligence and field force optimization
Give sales and medical field teams AI-assisted insights on HCP targeting, territory planning, and next-best-action — improving commercial execution without increasing headcount.
Regulatory document preparation
Accelerate the drafting, review, and quality-checking of regulatory submissions using AI — reducing preparation time while improving consistency and traceability.
Outcomes
What measurable change looks like.
Growth
Faster commercial ramp, improved HCP engagement, and more effective medical affairs at lower cost.
Efficiency
Significant reduction in pharmacovigilance and regulatory document processing time.
Operating advantage
A compliant AI operating model that scales across functions without introducing regulatory or safety risk.
Typical starting points
How clients engage.
From experiments to operations
Use the tools. Build the operating model.
Many teams in this sector are already experimenting with AI tools. Quantum Rise helps turn those experiments into governed workflows, trained teams, and measurable business outcomes.
Governed workflows
Connect AI tools to real business workflows with the controls, oversight, and auditability that matter.
Trained teams
Role redesign, adoption support, and change leadership so people use AI tools to create real value.
Measurable outcomes
Track business impact, tool ROI, and performance improvements to justify investment and guide next steps.